Keywords
periocular region
propranolol
beta-blockers
Doppler ultrasonography
blood flow
medical therapy
How to Cite
Abstract
This study investigates the clinical characteristics of infantile hemangiomas located in the periocular region and evaluates the effectiveness of propranolol-based medical therapy. The research was conducted between 2022 and 2026 and included 34 infants, in whom lesion localization, size, and vascular activity were assessed using clinical examination, photographic documentation, and color Doppler ultrasonography. All patients received propranolol at a dose of 1–2 mg/kg/day on an outpatient basis under cardiological monitoring. The results demonstrated a significant reduction in lesion size, blood flow velocity, and vascular activity after treatment
(P < 0.05), with early initiation associated with better clinical and hemodynamic outcomes. Color Doppler ultrasonography proved to be a reliable diagnostic tool for evaluating hemangioma activity, monitoring treatment response, and guiding individualized therapeutic strategies.
References
Goto K, Ozeki M, Yasue S, Endo S, Fukao T. Retrospective study of propranolol 2 or 3 mg/kg/day for infantile hemangioma. Pediatr Int. 2020;62(6):751–753.
Zhao J, Huang AH, Rainer BM, et al. Periocular infantile hemangiomas: characteristics, ocular sequelae, and outcomes. Pediatr Dermatol. 2019;36(6):830–834. https://doi.org/10.1111/pde.13925
Robb RM. Refractive errors associated with hemangiomas of the eyelids and orbit in infancy. Am J Ophthalmol. 1977;83(1):52–58. https://doi.org/10.1016/0002-9394(77)90191-X
Samuelov L, Kinori M, Rychlik K, et al. Risk factors for ocular complications in periocular infantile hemangiomas. Pediatr Dermatol. 2018;35(4):458–462. https://doi.org/10.1111/pde.13525
Ceisler EJ, Santos L, Blei F. Periocular hemangiomas: what every physician should know. Pediatr Dermatol. 2004;21(1):1–9. https://doi.org/10.1111/j.0736-8046.2004.21101.x
Jalil A, Maino A, Bhojwani R, et al. Clinical review of periorbital capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus. 2011;48(4):218–225. https://doi.org/10.3928/01913913-20100719-04
Léauté-Labrèze C, Prey S, Ezzedine K. Infantile hemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011;25(11):1245–1253. https://doi.org/10.1111/j.1468-3083.2011.04102.x
O TM, Ceisler E, Broude C, et al. Distribution and clinical characteristics of periorbital infantile hemangiomas. Facial Plast Surg Aesthet Med. 2023;25(2):172–178. https://doi.org/10.1089/fpsam.2022.0099
Chen WL, Lan YQ, Hong L, et al. Comprehensive management of infantile hemangiomas involving the periorbital region. Ann Plast Surg. 2022;89(4):391–394. https://doi.org/10.1097/SAP.0000000000003272
Hoornweg MJ, Saeed P, Tanck MW, et al. Comparison of intralesional corticosteroid and propranolol treatment of periorbital infantile hemangiomas: an outcome study of 61 cases. Eur J Ophthalmol. 2014;24(6):940–947. https://doi.org/10.5301/ejo.5000467
Wassef M, Blei F, Adams D, et al.; ISSVA Board and Scientific Committee. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136(1):e203–e214. https://doi.org/10.1542/peds.2014-3673
Sun LM, Xu Y, Xu MN, et al. Diagnosis and treatment of periorbital infantile hemangiomas: case series and literature review. Int J Pediatr Otorhinolaryngol. 2020;136:110157. https://doi.org/10.1016/j.ijporl.2020.110157
This work is licensed under a Creative Commons Attribution 4.0 International License.